share_log

Despite the Downward Trend in Earnings at PhiChem (SZSE:300398) the Stock Advances 8.7%, Bringing Five-year Gains to 21%

Despite the Downward Trend in Earnings at PhiChem (SZSE:300398) the Stock Advances 8.7%, Bringing Five-year Gains to 21%

儘管斐奇(SZSE:300398)的收益呈下降趨勢,但股價上漲了8.7%,使五年收益率達到21%
Simply Wall St ·  10/21 17:12

Generally speaking the aim of active stock picking is to find companies that provide returns that are superior to the market average. And while active stock picking involves risks (and requires diversification) it can also provide excess returns. For example, the PhiChem Corporation (SZSE:300398) share price is up 19% in the last 5 years, clearly besting the market return of around 13% (ignoring dividends). On the other hand, the more recent gains haven't been so impressive, with shareholders gaining just 8.3%, including dividends.

一般來說,積極的選股目標是找到那些提供高於市場平均回報的公司。雖然積極的選股涉及風險(並需要分散投資),但也可以提供超額回報。例如,飛凱材料(SZSE:300398)的股價在過去5年上漲了19%,明顯優於市場回報約13%(不計算分紅派息)。另一方面,最近的收益並不那麼令人印象深刻,股東僅獲得了8.3%的收益,包括分紅。

Since it's been a strong week for PhiChem shareholders, let's have a look at trend of the longer term fundamentals.

由於飛凱材料股東本週表現強勁,讓我們來看一下長期基本面的趨勢。

In his essay The Superinvestors of Graham-and-Doddsville Warren Buffett described how share prices do not always rationally reflect the value of a business. One flawed but reasonable way to assess how sentiment around a company has changed is to compare the earnings per share (EPS) with the share price.

在他的文章《格雷厄姆-多德斯維爾的超級投資人》中,禾倫·巴菲特描述了股票價格並不總是理性地反映公司價值的情況。一種有缺陷但合理的評估公司情緒如何變化的方法是將每股收益(EPS)與股票價格進行比較。

PhiChem's earnings per share are down 26% per year, despite strong share price performance over five years.

儘管在過去五年股價表現強勁,飛凱材料的每股收益每年下降26%。

The strong decline in earnings per share suggests the market isn't using EPS to judge the company. The falling EPS doesn't correlate with the climbing share price, so it's worth taking a look at other metrics.

每股收益的大幅下降表明市場並沒有使用EPS來評判這家公司。下滑的EPS與不斷攀升的股價不一致,因此值得看看其他指標。

We doubt the modest 0.5% dividend yield is attracting many buyers to the stock. On the other hand, PhiChem's revenue is growing nicely, at a compound rate of 14% over the last five years. In that case, the company may be sacrificing current earnings per share to drive growth.

我們懷疑微薄的0.5%股息率並沒有吸引很多買家購買該股票。另一方面,飛凱材料的營業收入增長勢頭不錯,在過去五年裏以14%的複合增長率增長。在這種情況下,公司可能正在犧牲當前每股收益來推動增長。

The graphic below depicts how earnings and revenue have changed over time (unveil the exact values by clicking on the image).

下面的圖表顯示了收益和營收隨時間的變化情況(通過單擊圖像揭示確切的值)。

big
SZSE:300398 Earnings and Revenue Growth October 22nd 2024
SZSE:300398 2024年10月22日盈利和營業收入增長

This free interactive report on PhiChem's balance sheet strength is a great place to start, if you want to investigate the stock further.

如果您想進一步調查這支股票,飛凱材料資產負債表實力的這份免費互動報告是一個很好的起點。

What About Dividends?

那麼分紅怎麼樣呢?

When looking at investment returns, it is important to consider the difference between total shareholder return (TSR) and share price return. The TSR is a return calculation that accounts for the value of cash dividends (assuming that any dividend received was reinvested) and the calculated value of any discounted capital raisings and spin-offs. Arguably, the TSR gives a more comprehensive picture of the return generated by a stock. As it happens, PhiChem's TSR for the last 5 years was 21%, which exceeds the share price return mentioned earlier. The dividends paid by the company have thusly boosted the total shareholder return.

在考慮投資回報時,重要的是考慮總股東回報(TSR)和股價回報之間的差異。 TSR是一種回報計算,考慮了現金分紅的價值(假設重新投資了任何分紅收入)以及任何折讓的資本籌集價值和拆分價值。可以說,TSR爲股票產生的回報提供了更全面的圖景。事實上,飛凱材料過去5年的TSR爲21%,超過了前面提到的股價回報。公司支付的分紅因此提高了總股東回報。

A Different Perspective

不同的觀點

It's nice to see that PhiChem shareholders have received a total shareholder return of 8.3% over the last year. Of course, that includes the dividend. That gain is better than the annual TSR over five years, which is 4%. Therefore it seems like sentiment around the company has been positive lately. Given the share price momentum remains strong, it might be worth taking a closer look at the stock, lest you miss an opportunity. It's always interesting to track share price performance over the longer term. But to understand PhiChem better, we need to consider many other factors. For instance, we've identified 3 warning signs for PhiChem that you should be aware of.

很高興看到飛凱材料的股東在過去一年裏獲得了總股東回報率爲8.3%。當然,這包括了分紅派息。這樣的增長優於過去五年的年度TSR,爲4%。因此,最近公司周圍的情緒似乎是積極的。鑑於股價勢頭依然強勁,也許值得更仔細地觀察一下這支股票,以免錯過機會。追蹤股價長期表現總是很有趣。但要更好地理解飛凱材料,我們需要考慮許多其他因素。例如,我們已經確定了3個飛凱材料的警告跡象,你應該知道。

Of course PhiChem may not be the best stock to buy. So you may wish to see this free collection of growth stocks.

當然,飛凱材料可能不是最佳的購買股票。所以您可能希望查看這些免費的成長股收藏。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Chinese exchanges.

請注意,本文引用的市場回報反映了目前在中國交易所上市的股票的市場加權平均回報。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有任何反饋?對內容有任何疑慮?請直接與我們聯繫。或者,發送電子郵件至editorial-team@simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論